IMDRF logo

Registration Opens for March IMDRF Meeting in Washington, DC

By MedTech Intelligence Staff
IMDRF logo

The 25th session of the International Medical Device Regulators Forum will be held March 11-15 in Washington, DC. The free event is open to the public and includes both in-person and virtual attendance options, Registration deadline is February 16.

Industry members and other stakeholders are invited to register for the 25th session of the International Medical Device Regulators Forum (IMDRF). The FDA, as the Chair and Secretariat of IMDRF, will be hosting this year’s session at the Ronald Reagan Building & International Trade Center in Washington, D.C., March 11-15, 2024. The free event is open to the public, virtually or in-person, on March 11-12. The last three days (March 13-15) are for IMDRF invitees only.

Stakeholders from across the international medical device community will exchange information, generate ideas, and hear updates on IMDRF’s various working groups as they strive to accelerate international medical device regulatory harmonization and convergence.

Day One will include the IMDRF Joint Workshop with the Global Medical Technology Alliance and the Global Diagnostic Imaging, Healthcare ICT, and Radiation Therapy Trade Association (DITTA) on Medical Device Regulatory Reliance

Day Two will include the IMDRF Stakeholder Open Forum

The deadline to register is February 16, 2024. Register here.


Related Articles

  • RQM plus logo

    Jordi labs and its team of Ph.D. analytical chemists developed a proprietary, multi-detector approach to ensure that all extractables are accurately characterized to comply with global materials testing regulatory requirements.

  • Microphone

    The call for abstracts for the MTI Regulatory Intelligence and Networking Summit is now open. The Summit, which will be held June 3-5, 2024, Washington, DC, offers education and discussion for the Medtech community as it works to develop processes,…

  • ISO_13485

    Device manufacturers and importers will have two years to modify their Quality Systems to meet the requirements of the QMSR rule by February 2, 2026.

  • Ramesh “Sunny” Balwani

    Balwani was found guilty on 10 counts of wire fraud and two counts of conspiracy to commit wire fraud for misleading investors about the financial health of the healthcare startup. He faced up to 20 years in prison for each…

About The Author

MedTech Intelligence